Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PReparing for OptimalPhase III/IV maTErnal Group B StreptococCal Vaccine Trials in Africa (PROTECT)

NCT06833957 is registered in ClinicalTrials.gov with Barcelona Institute for Global Health as lead sponsor.

NCT NCT06833957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06833957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PReparing for OptimalPhase III/IV maTErnal Group B StreptococCal Vaccine Trials in Africa (PROTECT)
Lead sponsor
Barcelona Institute for Global Health
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2025
Completion date
February 28, 2027
Enrollment
18,100 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

group b streptococcus, invasive bacterial diseases (ibd), maternal immunization